# Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cardiorenal-and-other-diabetes-related-outcomes-with-sglt-2-inhibitors-compared/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Moa Lugner,Naveed Sattar,Mervete Miftaraj,Jan Ekelund,Stefan Franzén,Ann‐Marie Svensson,Björn Eliasson |
| Citations | 59 |
| DOI | 10.1186/s12933-021-01258-x |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://cardiab.biomedcentral.com/counter/pdf/10.1186/s12933-021-01258-x |
| OpenAlex ID | https://openalex.org/W3138715254 |
| PMID | 33752680 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Jan Ekelund](https://scholariq.org/researchers/jan-ekelund/)

## Paper journal

- [Cardiovascular Diabetology](https://scholariq.org/journals/cardiovascular-diabetology/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.